1st Quarter - Report

OREGON HEALTH & SCIENCE UNIVERSITY for OREGON HEALTH & SCIENCE UNIVERSITY

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2017 $50,000 Replaced
1st Quarter - Amendment Apr 24, 2017 $50,000 Yes

What was lobbied

10 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

Maintaining the current charitable tax deduction.

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Protecting innovators from frivolous patent lawsuits: "Innovation Act" (HR 9).

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 9 (115th)

Veterans VET

Access to care for veterans and physician workforce issues.

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2017 funding for NIH, Title VII and VIII of the Public Health Services Act, Center for Disease Control, Agency for HealthCare Research and Quality, Healthcare Resources and Services Administration, Office of Refugee Resettlement; Maternal Child Health Bureau further continuing and C.R. Security Assistance Appropriations Act, 2017 (H.R. 2028); FY2017 Funding for National Science Foundation; FY 2017 funding for USGS Columbia River program; FY 2017 funding for Department of Defense Health Research and for environmental exposures biomarkers research and lung injury research; FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (HR 5054/ S.2956); FY2017 funding for Zika: "Zika Response Appropriations Act, 2016" (HR5243), Division B in "Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017" (HR 2577). FY2017 and FY2018 Departments of Labor, Health and Human Services, and Education, and related agencies Appropriations; health and science related funding issues.

LobbyistCovered position, as disclosed
DANIEL BATES —
SHEA MCCARTHY —
HARRIET MELVIN —
GARY PALMQUIST —
ANDREW ROSEBURG —
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2028 (115th), H.R. 5243 (115th), H.R. 5054 (115th), H.R. 2577 (115th), S. 2956 (115th)

Firearms/Guns/Ammunition FIR

FY 2017 Funding for Centers for Disease Control research on gun violence.

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Animal Welfare Act and Horse Protection Act; issues related to the use of animals in biomedical research.

LobbyistCovered position, as disclosed
DANIEL BATES —
SHEA MCCARTHY —
HARRIET MELVIN —
GARY PALMQUIST —
ANDREW ROSEBURG —
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Adequacy of health care workforce associated with expansion of health care coverage. Affordable Care Act (P.L. 111-148) repeal and Market Stabilization Proposed Rule, H.R. 1628 American Health Care Act of 2017; issues related to health care coverage.

LobbyistCovered position, as disclosed
DANIEL BATES —
SHEA MCCARTHY —
HARRIET MELVIN —
GARY PALMQUIST —
ANDREW ROSEBURG —
ABIGAIL TIBBS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1628 (115th)

Medicare/Medicaid MMM

Preventing cuts to Medicare Graduate Medical Education payments: "The Medicare IME Pool Act of 2015" (H.R. 3292); preventing cuts to Disproportionate Share Hospital Payments: "The Strengthening DSH and Medicare Through Subsidy Recapture and Payment Reform Act of 2015" (H.R. 3288); Preventing reductions to Hospital Inpatient and Outpatient PPS Payments: "The Medicare Crosswalk Hospital Code Development Act of 2015" (H.R. 3291), Medicare payments for Off-Campus Hospital outpatient departments; implementation of Section 603 "Bipartisan Budget Act of 2015)" (H.R. 1314), "Helping Hospitals Improve Patient Care Act of 2016" (H.R. 5273) 21st Century Cures Act (H.R. 34); CY 2017 Medicare Hospital Outpatient Prospective payment system proposed rule: Provider reimbursements for end of life care counseling; Additional Medicare support for Medicare Graduate Medical Education; Allowing nurse practitioners, certified nurse-midwives, and clinical nurse specialists to certify home health service for Medicare patients: "Home Health Care Planning Improvement Act" (S 578); Medicare payment for short hospital stays; Preventing reductions to the Medicaid program including the provider tax; Improvements to the Medicaid program for medically complex children: "Advancing Care for Exceptional Children Act of 2015" (H.R. 546/S 298).

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3291 (115th), H.R. 34 (115th), H.R. 1314 (115th), H.R. 3288 (115th), H.R. 546 (115th), H.R. 5273 (115th), H.R. 3292 (115th)

Pharmacy PHA

340b Drug Discount Program for safety net hospitals and Health Resources and Services Administration proposed omnibus guidance.

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Impact of Budget Control Act of 2011's Sequestration on medical research; use of animals in biomedical research; moving medical research from bench to bedside more quickly including greater sharing of research data, reducing administrative burden on medical researchers, streamline of clinical trials, increased flexibility in the FDAs approval process for drugs and devices tied with additional review in post-market: "21st Century Cures Act" (H.R. 34); FDA regulation of mitochondrial replacement therapy Sections 736 in "Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017" (H.R. 5054/S. 2956); importance of research using fetal tissue; importance of Small Business Innovation Research and Small Technology Transfer Research program; FDA regulation of laboratory developed test.

LobbyistCovered position, as disclosed
ABIGAIL TIBBS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 34 (115th), H.R. 5054 (115th), S. 2956 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.